DREAMTECH Co., Ltd. designs, develops, manufactures, and sells advanced electronic modules for smartphones, wearables, automotive applications, home appliances, medical devices, and IT products. The company offers printed circuit board assembly (PBA) modules; fingerprint sensor modules for biometric authentication, convergence solutions, and medical systems; optical sensors; compact camera modules; LED modules; touch modules; LCD display modules; wireless connectivity modules including Wi-Fi, Bluetooth, IoT (Wi-Fi + MCU, ZigBee + BLE), and combo modules; as well as IT components such as wireless earphones and laptops. Founded in 1998 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, DREAMTECH operates primarily in South Korea with international reach, targeting consumer electronics, automotive, healthcare, and convergence sectors, and employs approximately 445 people.
In recent developments, DREAMTECH completed a share buyback program announced on August 6, 2025, following a prior tranche update in September 2025 and an earlier buyback expiration in 2024 involving 576,220 shares; entered a joint investment agreement with bio-plasma company Plasmapp in April 2024 as a strategic investor; acquired Cardiac Insight in March 2022 to expand into heart health technology with products like Cardea Solo and Cardea 20/20; and underwent a spin-off from Uniquest Corporation in July 2023, where Uniquest divested a 33.2% stake via merger of its investment division into DREAMTECH.